已收盤 05-08 16:00:00 美东时间
+0.390
+2.68%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
Needham analyst Ryan Koontz reiterates Adtran Holdings (NASDAQ:ADTN) with a Buy and maintains $18 price target.
05-06 18:54
Adtran Networks announces annual general meeting Adtran Networks SE scheduled annual general meeting for June 15, 2026 in Munich. Shareholders to vote on proposal to carry forward full net profit of EUR 177,438,127.08, despite distribution cap of EUR 96,430,619.07 cited in meeting materials. Ballots
05-06 16:04
ADTRAN Holdings shares are trading lower. The company reported Q1 financial res...
05-05 21:24
Adtran Holdings (NASDAQ:ADTN) released first-quarter financial results and host...
05-05 21:16
Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance. Other stocks falling in pre-market trading.
05-05 20:02
For the second quarter of 2026, the Company expects revenue to be within a range of $283.0 million to $303.0 million. Non-GAAP operating margin is expected to be within a range of 5.0% to 9.0%.
05-05 13:36
Adtran (NASDAQ:ADTN) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. This is a 366.67 percent increase over earnings of $0.03 per share from the same
05-05 13:35
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11